NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Panobinostat for treating multiple myeloma after at least 2 previous treatments - NICE TAG TA380

Panobinostat for treating multiple myeloma after at least 2 previous treatments - NICE TAG TA380

1.1 Panobinostat in combination with bortezomib and dexamethasone is recommended, within its marketing authorisation, as an option for treating multiple myeloma, that is, for 'adult patients with relapsed and/or refractory multiple myeloma who have received at least 2 prior regimens including bortezomib and an immunomodulatory agent' when the company provides panobinostat with the discount agreed in the patient access scheme.

https://www.nice.org.uk/guidance/ta380

Site by Devopa
© Copyright 2019 NHS. All rights reserved.